Successful treatment of cutaneous metastatic melanoma with high-dose intralesional interleukin-2 treatment combined with cryosurgery
Corresponding Author
Antonio Martinez-Lopez
Dermatology Unit, Hospital Universitario Virgen de las Nieves, Granada, Spain
Correspondence Antonio Martinez-Lopez, Av Fuerzas Armadas, s/n, 18014. Granada, Spain. Email: [email protected]Search for more papers by this authorFrancisco Manuel Almazan-Fernandez
Melanoma Unit, Hospital Universitario San Cecilio, Granada, Spain
Search for more papers by this authorIsrael Perez-Lopez
Dermatology Unit, Hospital de Baza, Granada, Spain
Search for more papers by this authorPaula Aguayo-Carreras
Dermatology Unit, Hospital Universitario San Cecilio, Granada, Spain
Search for more papers by this authorLuis Salvador-Rodriguez
Dermatology Unit, Hospital Universitario Virgen de las Nieves, Granada, Spain
Search for more papers by this authorCarlos Cuenca-Barrales
Dermatology Unit, Hospital Universitario San Cecilio, Granada, Spain
Search for more papers by this authorSalvador Arias-Santiago
Dermatology Unit, Hospital Universitario Virgen de las Nieves, Granada, Spain
Medicine School, University of Granada, Spain
Search for more papers by this authorCorresponding Author
Antonio Martinez-Lopez
Dermatology Unit, Hospital Universitario Virgen de las Nieves, Granada, Spain
Correspondence Antonio Martinez-Lopez, Av Fuerzas Armadas, s/n, 18014. Granada, Spain. Email: [email protected]Search for more papers by this authorFrancisco Manuel Almazan-Fernandez
Melanoma Unit, Hospital Universitario San Cecilio, Granada, Spain
Search for more papers by this authorIsrael Perez-Lopez
Dermatology Unit, Hospital de Baza, Granada, Spain
Search for more papers by this authorPaula Aguayo-Carreras
Dermatology Unit, Hospital Universitario San Cecilio, Granada, Spain
Search for more papers by this authorLuis Salvador-Rodriguez
Dermatology Unit, Hospital Universitario Virgen de las Nieves, Granada, Spain
Search for more papers by this authorCarlos Cuenca-Barrales
Dermatology Unit, Hospital Universitario San Cecilio, Granada, Spain
Search for more papers by this authorSalvador Arias-Santiago
Dermatology Unit, Hospital Universitario Virgen de las Nieves, Granada, Spain
Medicine School, University of Granada, Spain
Search for more papers by this author
REFERENCES
- Aguado-Romeo, M. J., Benot-López, S., & Romero-Tabares, A. (2017). Electrochemotherapy for the treatment of unresectable locoregionally advanced cutaneous melanoma: A systematic review. Actas Dermo-Sifiliograficas, 108(2), 91–97.
- Byers, B. A., Temple-Oberle, C. F., Hurdle, V., & McKinnon, J. G. (2014). Treatment of in-transit melanoma with intra-lesional interleukin-2: A systematic review. Journal of Surgical Oncology, 110(6), 770–775.
- Leventhal, J. S., Odell, I. D., Imaeda, S., Maverakis, E., & King, B. A. (2016). Treatment of melanoma in-transit metastases with combination intralesional interleukin-2, topical imiquimod, and tretinoin 0.1% cream. JAAD Case Reports, 2, 114–116.
- Nouri, N., & Garbe, C. (2016). Intralesional immunotherapy as a strategy to treat melanoma. Expert Opinion on Biological Therapy, 16(5), 619–626.
- Palathinkal, D. M., Sharma, T. R., Koon, H. B., & Bordeaux, J. S. (2014). Current systemic therapies for melanoma. Dermatologic Surgery, 40(9), 948–963.
- Schvartsman, G., Perez, K., Flynn, J. E., Myers, J. N., & Tawbi, H. (2017). Safe and effective administration of T-VEC in a patient with heart transplantation and recurrent locally advanced melanoma. Journal for Immunotherapy of Cancer, 5(1), 45.
- Sersa, G., Cemazar, M., & Snoj, M. (2009). Electrochemotherapy of tumours. Current Oncology (Toronto, Ont.), 16(2), 34–35.
- Shi, V. Y., Tran, K., Patel, F., Leventhal, J., Konia, T., Fung, M. A., … Maverakis, E. (2015). 100% Complete response rate in patients with cutaneous metastatic melanoma treated with intralesional interleukin (IL)-2, imiquimod, and topical retinoid combination therapy: Results of a case series. Journal of the American Academy of Dermatology, 73(4), 645–654.
- Tarhini, A. A., & Agarwala, S. S. (2005). Interleukin-2 for the treatment of melanoma. Current Opinion in Investigational Drugs (London, England: 2000), 6, 1234–1239.
